Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-6,334
Closed -$1.31M 63
2018
Q3
$1.31M Sell
6,334
-3,033
-32% -$598K 2.08% 8
2018
Q2
$1.73M Sell
9,367
-1,997
-18% -$353K 2.63% 7
2018
Q1
$1.94M Buy
11,364
+3,280
+41% +$602K 1.33% 9
2017
Q4
$1.41M Buy
8,084
+7,124
+742% +$1.26M 0.97% 9
2017
Q3
$179K Buy
+960
New +$170K 0.11% 198
2017
Q2
Sell
-200
Closed -$33K 298
2017
Q1
$33K Buy
+200
New +$33.2K 0.02% 230

Other funds holding AMGN

TLP Group's AMGN Position: Q4 2018 in Review

TLP Group sold out of Amgen (AMGN) in Q4 2018, closing a stake of 6,334 shares — an estimated $1.31M sold.

TLP Group first reported a position in AMGN in Q1 2017 and held it in 6 quarters. The position peaked at $1.94M in Q1 2018. 1,891 funds tracked by Wall St. Rank hold AMGN as of Q4 2018.

  • TLP Group reported no remaining Amgen position as of Q4 2018 after selling out during the quarter.
  • TLP Group sold 6,334 Amgen shares in Q4 2018, an estimated $1.31M.
  • TLP Group first reported a position in Amgen in Q1 2017 and held it in 6 quarters.
  • TLP Group's Amgen position peaked at $1.94M in Q1 2018.
  • 1,891 funds tracked by Wall St. Rank held Amgen as of Q4 2018.

Based on TLP Group's 13F filing for Q4 2018, filed 14 Feb 2019.